Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2024-01-02 00:00:00 ET · period of report 2023-12-28 · accession 0000874015-24-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-02 | 2023-12-28 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | F - Tax | $50.50 | -43.8K | 77.1K | -36% | -$2.21M |
| D | 2024-01-02 | 2023-12-28 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $47.34 | +45.2K | 120.9K | +60% | +$2.14M |
| D | 2024-01-02 | 2023-12-28 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $0.00 | -45.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-28 | F | D | 43,798 | $50.50 | 77,086 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-28 | M | A | 45,225 | $47.34 | 120,884 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-12-28 | M | D | 45,225 | $0.00 | 0 | D | $47.34 · 2021-01-03 to 2024-01-02 | 45,225 Common Stock |